IOVA R&D to Revenue
Iovance Biotherapeutics Inc · R&D to Revenue
IOVA R&D to Revenue
Latest reported59.26%period ending
IOVA Quarterly R&D/Revenue (0.00% → 59.26%)
Latest values, visible window
High-resolution chart · PNG
IOVA r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 59.2581% | |
| 87.4801% | |
| 82.0585% | |
| 111.4432% | |
| 129.984% | |
| 154.0122% | |
| 98.0053% | |
| 116.5505% | |
| 199.5885% | |
| 11,158.4615% | |
| 18,147.3029% | |
| 18,662.2601% | |
| 36,280.2521% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |